{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:28:37Z","timestamp":1773350917502,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06331-2","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:52:53Z","timestamp":1773312773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of pathological T stage and independent survival benefit of adjuvant chemotherapy for upper tract urothelial carcinoma: real-world data from a high-volume Vietnamese center"],"prefix":"10.1007","volume":"44","author":[{"given":"Kinh Luan","family":"Thai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nho Tinh","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Tung","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc Huy","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Yee","family":"Tiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David-Dan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuan Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan Thai","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam Minh","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"6","key":"6331_CR1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","volume":"209","author":"JA Coleman","year":"2023","unstructured":"Coleman JA, Clark PE, Bixler BR, Buckley DI, Chang SS, Chou R et al (2023) Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA\/SUO Guideline. J Urol 209(6):1071\u20131081","journal-title":"J Urol"},{"issue":"1","key":"6331_CR2","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7\u201333","journal-title":"CA Cancer J Clin"},{"key":"6331_CR3","first-page":"2185","volume-title":"Urothelial Tumors of the Upper Urinary Tract and Ureter. Campbell Walsh Wein Urology","author":"P Kallidonis","year":"2020","unstructured":"Kallidonis P, Liatsikos E (2020) Urothelial Tumors of the Upper Urinary Tract and Ureter. Campbell Walsh Wein Urology, 12 edn. Elsevier, Philadelphia, pp 2185\u20132198","edition":"12"},{"issue":"1","key":"6331_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12894-021-00876-7","volume":"21","author":"A Soualhi","year":"2021","unstructured":"Soualhi A, Rammant E, George G, Russell B, Enting D, Nair R et al (2021) The incidence and prevalence of upper tract urothelial carcinoma: a systematic review. BMC Urol 21(1):110","journal-title":"BMC Urol"},{"issue":"12","key":"6331_CR5","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/iju.14682","volume":"28","author":"C Colla Ruvolo","year":"2021","unstructured":"Colla Ruvolo C, Wurnschimmel C, Nocera L, Wenzel M, Tian Z, Shariat SF et al (2021) Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study. Int J Urol 28(12):1247\u20131252","journal-title":"Int J Urol"},{"issue":"6","key":"6331_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E et al (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115(6):1224\u20131233","journal-title":"Cancer"},{"key":"6331_CR7","first-page":"2199","volume-title":"Campbell Walsh Wein Urology","author":"TW Jarret","year":"2020","unstructured":"Jarret TW, Smith AK, Matin SF (2020) Surgical Management of Upper Urinary Tract Urothelial Tumors. Campbell Walsh Wein Urology, 12 ed. Elsevier, Philadelphia, pp 2199\u2013225","edition":"12 ed"},{"issue":"10232","key":"6331_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395(10232):1268\u20131277","journal-title":"Lancet"},{"issue":"1","key":"6331_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupret","year":"2023","unstructured":"Roupret M, Seisen T, Birtle AJ, Capoun O, Comperat EM, Dominguez-Escrig JL et al (2023) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur Urol 84(1):49\u201364","journal-title":"Eur Urol"},{"issue":"7","key":"6331_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.urolonc.2025.02.014","volume":"43","author":"F Di Bello","year":"2025","unstructured":"Di Bello F, Siech C, de Angelis M, Rodriguez Pe\u00f1aranda N, Jannello LMI, Tian Z et al (2025) Bladder cuff excision at radical nephroureterectomy improved survival in upper tract urothelial carcinoma. Urol Oncol 43(7):442.e1-.e7","journal-title":"Urol Oncol"},{"key":"6331_CR11","doi-asserted-by":"crossref","unstructured":"Di Bello F, de Angelis M, Siech C, Pe\u00f1aranda NR, Tian Z, Goyal JA et al (2025) Non-caucasian race\/ethnicity predisposes to unfavorable stage and grade at upper tract urothelial carcinoma diagnosis. J Racial Ethnic Health Disparities","DOI":"10.1007\/s40615-025-02285-0"},{"issue":"4","key":"6331_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.eururo.2014.08.003","volume":"67","author":"G Ploussard","year":"2015","unstructured":"Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Roupret M et al (2015) Conditional survival after radical nephroureterectomy for upper tract carcinoma. Eur Urol 67(4):803\u201312","journal-title":"Eur Urol"},{"issue":"1","key":"6331_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/21681805.2019.1710562","volume":"54","author":"NH Azawi","year":"2020","unstructured":"Azawi NH, Naeraa SH, Subhi Y, Vasquez JL, Norus T, Dahl C et al (2020) Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark. Scand J Urol 54(1):58\u201364","journal-title":"Scand J Urol"},{"issue":"5","key":"6331_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.euo.2020.11.005","volume":"4","author":"C Colla Ruvolo","year":"2021","unstructured":"Colla Ruvolo C, Nocera L, Stolzenbach LF, Wenzel M, Cucchiara V, Tian Z et al (2021) Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma. Eur Urol Oncol 4(5):792\u2013801","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"6331_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/jso.25877","volume":"121","author":"G Rosiello","year":"2020","unstructured":"Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, Deuker M et al (2020) Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract. J Surg Oncol 121(7):1154\u20131161","journal-title":"J Surg Oncol"},{"key":"6331_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.723669","volume":"11","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Wang Y, Zhang N, Mao X, Huang Y, Huang J et al (2021) Influence of American Society of Anesthesiologists score on oncologic outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: a large-sample study in two institutions. Front Oncol 11:723669","journal-title":"Front Oncol"},{"key":"6331_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1012292","volume":"12","author":"J Gao","year":"2022","unstructured":"Gao J, Liu J, Liu J, Lin S, Ding D (2022) Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China. Front Oncol 12:1012292","journal-title":"Front Oncol"},{"key":"6331_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.euros.2022.04.007","volume":"40","author":"N Hendriks","year":"2022","unstructured":"Hendriks N, Baard J, Beerlage HP, Schout BMA, Doherty KSG, Pelger RCM et al (2022) Survival and long-term effects of kidney-sparing surgery versus radical nephroureterectomy on kidney function in patients with upper urinary tract urothelial carcinoma. Eur Urol Open Sci 40:104\u201311","journal-title":"Eur Urol Open Sci"},{"issue":"3","key":"6331_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK et al (2014) Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol 65(3):650\u20138","journal-title":"Eur Urol"},{"issue":"1","key":"6331_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H et al (2014) Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 65(1):210\u2013217","journal-title":"Eur Urol"},{"issue":"1","key":"6331_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/bju.16902","volume":"137","author":"F Di Bello","year":"2026","unstructured":"Di Bello F, Gallioli A, Cannoletta D, Mancon S, Territo A, Di\u00e9guez L et al (2026) Intravesical recurrence after therapeutic ureteroscopy for upper tract urothelial carcinoma: a meta-analysis. BJU Int 137(1):26\u201335","journal-title":"BJU Int"},{"issue":"1","key":"6331_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73699-5","volume":"10","author":"K Wu","year":"2020","unstructured":"Wu K, Liang J, Lu Y (2020) Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma. Sci Rep 10(1):16600","journal-title":"Sci Rep"},{"key":"6331_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235935","author":"TM Chien","year":"2021","unstructured":"Chien TM, Lee HY, Singla N, Margulis V, Lotan Y, Woldu SL et al (2021) Prognostic factors for contralateral recurrence of upper tract urothelial carcinoma after nephroureterectomy: a large multiregional study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13235935","journal-title":"Cancers (Basel)"},{"issue":"5","key":"6331_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","volume":"79","author":"JJ Leow","year":"2021","unstructured":"Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J (2021) Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy. Eur Urol 79(5):635\u2013654","journal-title":"Eur Urol"},{"issue":"13","key":"6331_CR25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1200\/JCO.23.01659","volume":"42","author":"AJ Birtle","year":"2024","unstructured":"Birtle AJ, Jones R, Chester J, Lewis R, Biscombe K, Johnson M et al (2024) Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT trial. J Clin Oncol 42(13):1466\u201371","journal-title":"J Clin Oncol"},{"issue":"10","key":"6331_CR26","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1245\/s10434-024-15814-8","volume":"31","author":"F Di Bello","year":"2024","unstructured":"Di Bello F, Jannello LMI, Siech C, de Angelis M, Rodriguez Pe\u00f1aranda N, Tian Z et al (2024) Adjuvant Systemic Therapy Improved Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Ann Surg Oncol 31(10):7229\u20137236","journal-title":"Ann Surg Oncol"},{"key":"6331_CR27","doi-asserted-by":"crossref","unstructured":"Siech C, de Angelis M, Jannello LMI, Di Bello F, Rodriguez Pe\u00f1aranda N, Goyal JA et al (2025) Upper urinary tract urothelial carcinoma diagnosis effect on life expectancy relative to population-based controls: a retrospective analysis. Urol Int. 1\u201310","DOI":"10.1159\/000548236"},{"issue":"1","key":"6331_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-025-05997-4","volume":"43","author":"A Gallioli","year":"2025","unstructured":"Gallioli A, Basile G, Cannoletta D, Territo A, Afferi L, Izquierdo P et al (2025) Systematic biopsies of the upper urinary tract: a tool to improve the diagnostic accuracy of ureteroscopy and characterization of upper tract urothelial cancer. World J Urol 43(1):614","journal-title":"World J Urol"},{"issue":"1","key":"6331_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00345-025-05626-0","volume":"43","author":"C Siech","year":"2025","unstructured":"Siech C, Jannello LMI, de Angelis M, Di Bello F, Rodriquez Pe\u00f1aranda N, Goyal JA et al (2025) Endoscopic ablation versus nephroureterectomy in localized low-grade upper tract urothelial carcinoma: a comparison in terms of cancer-specific and other-cause mortality. World J Urol 43(1):241","journal-title":"World J Urol"},{"issue":"11","key":"6331_CR30","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1245\/s10434-012-2453-9","volume":"19","author":"P Colin","year":"2012","unstructured":"Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A et al (2012) Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol 19(11):3613\u201320","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06331-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:53:00Z","timestamp":1773312780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06331-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6331"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06331-2","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the University of Medicine and Pharmacy at Ho Chi Minh City, with Approval No. 1218\/H\u0110\u0110\u0110-\u0110HYD, dated December 11, 2023. The Institutional Review Board of the University of Medicine and Pharmacy at Ho Chi Minh City waived the need for individual informed consent as this was a retrospective study using anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"233"}}